Funder
National Institutes of Health
Novartis Pharmaceuticals Corp
Reference37 articles.
1. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials;Baigent;Lancet,2010
2. A test in context: lipoprotein(a): diagnosis, prognosis, controversies, and emerging therapies;Tsimkas;J Am Coll Cardiol,2017
3. Lipoprotein (a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality;JAMA,2009
4. Extreme lipoprotein(a) levels and improved cardiovascular risk prediction;Kamstrup;J Am Coll Cardiol,2013
5. Genetic variants associated with Lp(a) lipoprotein level and coronary disease;Clarke;N Engl J Med,2009
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献